156 related articles for article (PubMed ID: 37098697)
1. Chemotherapeutic drugs induced female reproductive toxicity and treatment strategies.
Bhardwaj JK; Bikal P; Sachdeva SN
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23371. PubMed ID: 37098697
[TBL] [Abstract][Full Text] [Related]
2. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
3. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
Yuksel A; Bildik G; Senbabaoglu F; Akin N; Arvas M; Unal F; Kilic Y; Karanfil I; Eryılmaz B; Yilmaz P; Ozkanbaş C; Taskiran C; Aksoy S; Guzel Y; Balaban B; Ince U; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2926-35. PubMed ID: 26466914
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
[TBL] [Abstract][Full Text] [Related]
6. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
[TBL] [Abstract][Full Text] [Related]
7. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of chemotherapy and radiation on female reproduction.
Meirow D; Biederman H; Anderson RA; Wallace WH
Clin Obstet Gynecol; 2010 Dec; 53(4):727-39. PubMed ID: 21048440
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis.
Zhang S; Liu Q; Chang M; Pan Y; Yahaya BH; Liu Y; Lin J
Cell Death Dis; 2023 May; 14(5):340. PubMed ID: 37225709
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced ovarian damage and protective strategies.
Zhao P; Guo C; Du H; Xiao Y; Su J; Wang X; Yeung WSB; Li G; Wang T
Hum Fertil (Camb); 2023 Oct; 26(4):887-900. PubMed ID: 38054300
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
13. Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants.
Ghafouri-Fard S; Shoorei H; Abak A; Seify M; Mohaqiq M; Keshmir F; Taheri M; Ayatollahi SA
Biomed Pharmacother; 2021 Oct; 142():112040. PubMed ID: 34416630
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
Szymanska KJ; Tan X; Oktay K
Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Antioxidants on Cyclophosphamide-Induced Ovarian Toxicity.
Barberino RS; Silva RLS; Palheta Junior RC; Smitz JEJ; Matos MHT
Biopreserv Biobank; 2023 Apr; 21(2):121-141. PubMed ID: 35696235
[TBL] [Abstract][Full Text] [Related]
16. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
17. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review.
Hao X; Anastácio A; Liu K; Rodriguez-Wallberg KA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31548505
[TBL] [Abstract][Full Text] [Related]
19. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin.
Morgan S; Lopes F; Gourley C; Anderson RA; Spears N
PLoS One; 2013; 8(7):e70117. PubMed ID: 23922929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
